The FDA is investigating a safety signal from Takeda’s rare disease med Adzynma. Otsuka won a first-in-class FDA approval to ...
Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall ...
Court clears path Purdue Pharma opioid settlement, confirming the $7.5B plan and enabling victim compensation and company reorganization.
America wants to reduce its reliance on Chinese supply chains, since it remains in a trade war that is only temporarily on hold. The government frets already about China’s chokehold on active drug ...
Medicus Pharma Ltd. (Nasdaq:MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical ...
Sam Altman’s longevity startup Retro Bio seeks to raise $5 billion valuation; Trump pollster advises House GOP on healthcare ...
Texas Attorney General Secures Purdue Pharma Bankruptcy Plan to Bolster Opioid Crisis Accountability
AG Paxton secures a deal with Purdue Pharma for bankruptcy reorganization, creating Knoa Pharma and a Master Creditor Trust.
The hospital lobby has filed a lawsuit seeking to block the federal government’s 340B Rebate Model Pilot Program, which is ...
The move clears a path for the OxyContin maker to exit its six-year bankruptcy and resolve mass lawsuits.
Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback